Needham & Company LLC Boosts Trulieve Cannabis (OTCMKTS:TCNNF) Price Target to $13.50

Trulieve Cannabis (OTCMKTS:TCNNFFree Report) had its price objective upped by Needham & Company LLC from $6.50 to $13.50 in a research report released on Friday morning, Benzinga reports. Needham & Company LLC currently has a buy rating on the stock.

Trulieve Cannabis Trading Down 2.1 %

Shares of Trulieve Cannabis stock opened at $10.17 on Friday. Trulieve Cannabis has a 52-week low of $3.42 and a 52-week high of $11.96. The company has a 50 day moving average of $7.94 and a 200 day moving average of $6.24.

About Trulieve Cannabis

(Get Free Report)

Trulieve Cannabis Corp., together with its subsidiaries, operates as a medical cannabis company. The company cultivates and produces products in-house and distributes its products to Trulieve branded stores (dispensaries) in Florida, as well as through home delivery. It produces flowers, edibles, vaporizer cartridge, concentrates, topicals, capsules, tinctures, dissolvable powders, and nasal sprays under the Avenue, Cultivar Collection, Muse, Modern Flower, Alchemy, Momenta, Sweet Talk, Co2lors, Loveli, and Roll One brands.

Further Reading

Receive News & Ratings for Trulieve Cannabis Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Trulieve Cannabis and related companies with MarketBeat.com's FREE daily email newsletter.